Cargando…
Abnormal alternative splicing promotes tumor resistance in targeted therapy and immunotherapy
Abnormally alternative splicing events are common hallmark of diverse types of cancers. Splicing variants with aberrant functions play an important role in cancer development. Most importantly, a growing body of evidence has supported that alternative splicing might play a significant role in the th...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Neoplasia Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039720/ https://www.ncbi.nlm.nih.gov/pubmed/33774500 http://dx.doi.org/10.1016/j.tranon.2021.101077 |